Biobizkaia
Centro de investigación
University of Newcastle Australia
Newcastle, AustraliaPublicaciones en colaboración con investigadores/as de University of Newcastle Australia (24)
2024
-
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Journal of Neurology, Vol. 271, Núm. 9, pp. 5813-5824
-
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study
CNS Drugs, Vol. 38, Núm. 11, pp. 921-930
-
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study
PLOS Digital Health, Vol. 3, Núm. 7
-
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
Journal of Neurology, Neurosurgery and Psychiatry
-
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
Journal of Neurology, Neurosurgery and Psychiatry
2023
-
Surgeons’ perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey
World Journal of Emergency Surgery, Vol. 18
2022
-
Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180
Computer methods and programs in biomedicine
-
Should brachytherapy be added to external beam radiotherapy for prostate cancer?
The Lancet Oncology, Vol. 23, Núm. 1, pp. 23-25
2021
-
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78
-
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
Computer Methods and Programs in Biomedicine, Vol. 208
-
Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade
Journal of global health, Vol. 11, pp. 15003
2019
-
Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS
American Journal of Human Genetics, Vol. 105, Núm. 1, pp. 151-165
2018
-
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis
Multiple Sclerosis Journal, Vol. 24, Núm. 5, pp. 642-652
2017
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
The Lancet, Vol. 390, Núm. 10091, pp. 231-266
-
Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response
Brain, Vol. 140, Núm. 9, pp. 2426-2443
-
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
The Lancet Neurology, Vol. 16, Núm. 4, pp. 271-281
2016
-
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 87, Núm. 12, pp. 1343-1349
2015
-
Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis
JAMA Neurology, Vol. 72, Núm. 4, pp. 405-413
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323